A new antivirulence drug that can render Methicillin Resistant Staphylococcus Aureus (MRSA) and Streptococcus pyogenes bacteria ineffective by stopping the production of disease causing toxins has been developed by a researcher at Case Western Reserve University. Menachem Shoham, PhD, associate professor of biochemistry at Case Western Reserve University School of Medicine, MRSA infections are a growing public health concern, causing thousands of deaths ...Saturday 15 September 2012
Antivirulence Drug That can Render MRSA and Strep Bacteria Ineffective Developed
A new antivirulence drug that can render Methicillin Resistant Staphylococcus Aureus (MRSA) and Streptococcus pyogenes bacteria ineffective by stopping the production of disease causing toxins has been developed by a researcher at Case Western Reserve University. Menachem Shoham, PhD, associate professor of biochemistry at Case Western Reserve University School of Medicine, MRSA infections are a growing public health concern, causing thousands of deaths ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment